meddevicedb.com FDA Device Reference

F&P Optiflow Nasal Oxygen Cannula with CO2 Sampling

K201723 Class II Traditional
Decision Date
2021-03-16
Sponsor / Applicant
Fisher & Paykel Healthcare, Ltd.

Technical Specification

510(k) Submission ID K201723
Product Code BTT
Medical Specialty / Panel Anesthesiology
Regulation Citation 21 CFR 868.5450
Decision Date 2021-03-16
Clearance Pathway Traditional

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

F&P Optiflow Nasal Oxygen Cannula with CO2 Sampling received FDA 510(k) clearance under submission number K201723, sponsored by Fisher & Paykel Healthcare, Ltd.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Anesthesiology review panel. The statutory decision date of record is 2021-03-16.

Classification & Regulation

This clearance is catalogued under FDA product code BTT and 21 CFR 868.5450, within the Anesthesiology review panel as a Class II device.